SCHEMBL29935588

SCHEMBL29935588

O=Cc1ccc2nccc(O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.47
KDM4E B2RXH2 6/20 0.47
RAB9A P51151 3/20 0.47
PTGS2 P35354 1/20 0.47
ALDH1A1 P00352 7/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 3/20 0.41
LMNA P02545 1/20 0.41
CASP3 P42574 1/20 0.41
HTT P42858 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
NPC1 O15118 3/20 0.40
HSP90AA1 P07900 1/20 0.40
IDO1 P14902 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH5A1 P51649 3/20 0.40
ABAT P80404 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4587473 1.00 ERN1 (0.47) ERN1KDM4ERAB9APTGS2ALDH1A1
SCHEMBL29955516 0.86 KDM4E (0.47) ERN1KDM4ERAB9APTGS2ALDH1A1
SCHEMBL6201297 0.79 NR4A2 (0.56) ERN1KDM4ERAB9AALDH1A1MEN1
SCHEMBL4585191 0.79 SMN1; SMN2 (0.47) ERN1KDM4ERAB9AALDH1A1MEN1
SCHEMBL18525595 0.79 ERN1 (0.44) ERN1KDM4ERAB9AMEN1KMT2A
SCHEMBL4389687 0.79 ALDH1A1 (0.40) ERN1KDM4ERAB9APTGS2ALDH1A1
SCHEMBL732379 0.79 ALDH1A1 (0.47) ERN1KDM4ERAB9AALDH1A1MEN1
SCHEMBL29935762 0.79 SMN1; SMN2 (0.47) ERN1KDM4ERAB9AALDH1A1MEN1
SCHEMBL13591344 0.78 KDM4E (0.39) ERN1KDM4ERAB9APTGS2ALDH1A1
SCHEMBL4586321 0.78 LMNA (0.57) KDM4ERAB9AALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ERN1 3219/4885KDM4E 2437/4885RAB9A 936/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH ERN1 3111/4885KDM4E 3565/4885RAB9A 1784/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ERN1 3219/4885KDM4E 2437/4885RAB9A 936/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP ERN1 3219/4885KDM4E 2437/4885RAB9A 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.